- Bart van Rhijn, CFO of Nanobiotix (NBTX, Financial), will speak at the H.C. Wainwright 3rd Annual BioConnect Investor Conference.
- The presentation is scheduled for May 20, 2025, at 5:00 pm EDT in New York.
- The event will be webcast live and available for replay on Nanobiotix's investor relations website.
Nanobiotix (NASDAQ: NBTX), a leading biotechnology company specializing in nanoparticle-based cancer treatments, is set to participate in the H.C. Wainwright 3rd Annual BioConnect Investor Conference at NASDAQ. The company's Chief Financial & Business Officer, Bart van Rhijn, will be presenting a fireside chat on Tuesday, May 20, 2025, at 5:00 pm EDT in New York.
The presentation will be webcast live, providing an opportunity for investors and stakeholders to engage with the company’s insights on its pioneering therapeutic approaches. The webcast will be accessible on the events page of the Investors section on Nanobiotix's official website, ensuring broad accessibility. A replay will also be available following the event for those unable to tune in live.
Nanobiotix, incorporated in 2003 and headquartered in Paris, France, is a late-stage clinical company listed on both Euronext Paris and the Nasdaq Global Select Market since December 2020. The company leverages cutting-edge nanotechnology platforms focusing on oncology, bioavailability, and central nervous system disorders to expand treatment possibilities for major diseases globally.
